Recently, in 2021, the first “Yangtze River Delta Medical Device High-quality Development Summit Forum” was held in Jiashan, Zhejiang. The forum was hosted by the Shanghai, Jiangsu, Zhejiang and Anhui drug supervision departments as the guiding unit and the China Chamber of Commerce for Import and Export of Medicines and Health Products. Wang Lanming, inspector of National Medical Products Administration Medical Device Registration Department, Wang Shucai, deputy director of National Medical Products Administration Medical Device Supervision Department, leaders of Shanghai, Jiangsu and Anhui Food and Drug Administration, Dong Geng, drug safety director of Zhejiang Food and Drug Administration, and Xu Mingyang, deputy secretary of Jiashan County Committee and county magistrate attended the summit.
With the theme of “eco-green, collaborative innovation and high-quality development”, the forum brought together academicians, regulators, think tank experts and more than 400 elite representatives of enterprises to discuss the policy priorities and practical paths of regional collaborative governance, and look forward to the future development trend of medical devices in production, learning and research.
Wang Lanming explained the changes in the registration management of medical devices, the legislative background and the progress of supporting regulations in the newly revised Regulations on the Supervision and Administration of Medical Devices.
Wang Shucai explained the legislative background and post-marketing supervision requirements of the newly revised Regulations on the Supervision and Administration of Medical Devices.
Dong Geng said in his speech that Zhejiang is willing to join hands with “two provinces and one city” to build a national leading medical device industry cluster, promote high-end medical devices to become a benchmark industry for the integration and development of “three major science and technology highlands”, and jointly build a world-class medical device advanced manufacturing cluster in the Yangtze River Delta.
In the roundtable forum, representatives from Roche, Yisi Medical, Zhende, Jiashi Guorun and other enterprises, together with leaders of the drug supervision department and the head of the Yangtze River Delta Smart Medical Alliance, discussed the new path of medical device innovation and development under the new Regulations.
At the meeting, the Yangtze River Delta Regional Cooperation Office, China Medical Insurance Chamber of Commerce Medical Device International Cooperation Branch, Yangtze River Delta City Economic Coordination Committee Smart Medical Development Alliance, and medical device industry associations in Shanghai, Jiangsu, Zhejiang and Anhui provinces jointly established the “Yangtze River Delta Medical Device High-quality Collaborative Development Alliance” and signed the “Yangtze River Delta Medical Device High-quality Collaborative Development Alliance Proposal”.
The holding of this forum will provide reference for the high-quality development of medical devices in the Yangtze River Delta and even the whole country. Under the background of domestic and international double circulation, the medical device industry will “go out” to benefit more overseas people on the basis of empowering domestic patients.
(Source: Jiashan County Science and Technology Bureau)